Search Clinical Trials
Withdrawn
Rituximab for GVHD (External Link)
Acute graft-versus-host disease (aGVHD), one of the most important complications of allogeneic hematopoietic stem cell transplantation (HSCT) is associated with significant morbidity and mortality. Grades II to IV aGVHD occur …
Baylor Role:
Lead Sponsor